Patents by Inventor Geoffrey Oxnard

Geoffrey Oxnard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NON-INVASIVE BLOOD BASED MONITORING OF GENOMIC ALTERATIONS IN CANCER
    Publication number: 20220090203
    Abstract: The invention provides methods to monitor cell free nucleic acids.
    Type: Application
    Filed: November 12, 2020
    Publication date: March 24, 2022
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Pasi A. Janne, Cloud P. Paweletz, Geoffrey Oxnard, Yanan Kuang
  • NON-INVASIVE BLOOD BASED MONITORING OF GENOMIC ALTERATIONS IN CANCER
    Publication number: 20210207223
    Abstract: The invention provides methods to monitor cell free nucleic acids.
    Type: Application
    Filed: November 12, 2020
    Publication date: July 8, 2021
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Pasi A. Janne, Cloud P. Paweletz, Geoffrey Oxnard, Yanan Kuang
  • Non-invasive blood based monitoring of genomic alterations in cancer
    Patent number: 10865451
    Abstract: The invention provides methods to monitor cell free nucleic acids.
    Type: Grant
    Filed: June 11, 2014
    Date of Patent: December 15, 2020
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Pasi A. Janne, Cloud P. Paweletz, Geoffrey Oxnard, Yanan Kuang
  • NON-INVASIVE BLOOD BASED MONITORING OF GENOMIC ALTERATIONS IN CANCER
    Publication number: 20160138112
    Abstract: The invention provides methods to monitor cell free nucleic acids.
    Type: Application
    Filed: June 11, 2014
    Publication date: May 19, 2016
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Pasi A. Janne, Cloud P. Paweletz, Geoffrey Oxnard, Yanan Kuang